AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtin M 3mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Shinto Organics (P) Limited

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimtin M 3mg/500mg Tablet ER

Diabetic patients using the extended-release Glimtin M 3mg/500mg tablet, an anti-diabetic medication, should adhere to the prescribed dosage and timing for optimal blood glucose management. This dual-action formulation aids in regulating blood sugar in adult type 2 diabetes. Ingestion should coincide with meals, maintaining consistent daily intake for maximum efficacy. Dosage adjustments, determined by your physician based on blood sugar monitoring, may occur. Discontinuing this medication without medical consultation is strongly discouraged; abrupt cessation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, dizziness, headaches, and tremors. Carrying readily available glucose sources, such as sugary snacks or juice, is crucial for prompt management. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is another potential consequence. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women should seek medical advice before using this medication. Regular blood sugar checks, alongside potential blood tests to monitor blood cell counts and liver function, are recommended under medical supervision.

Uses of Glimtin M 3mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimtin M 3mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimtin M 3mg/500mg Extended-Release Tablet with a meal.

Common Side effects of Glimtin M 3mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtin M 3mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the Glimtin M 3mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Glimtin M 3mg/500mg Tablet ER works:

Glimtin M 3mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimtin M 3mg/500mg ER tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimtin M 3mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimtin M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtin M 3mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimtin M 3mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimtin M 3mg/500mg Tablet ER :

Should you forget to take a Glimtin M 3mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtin M 3mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimtin M 3mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glimtin M 3mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Glimtin M, if you experience these symptoms.
Glimtin M 3mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimtin M 3mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimtin M 3mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Glimtin M 3mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimtin M 3mg/500mg Tablet ER and alcohol is unsafe. Alcohol can exacerbate the medication's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimtin M 3mg/500mg Table...
94
MRP 114
17% off